A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application ...
11monon MSN
How the mRNA technology behind COVID-19 vaccines could ‘turbo-charge’ cancer treatments
Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did not get the vaccine. View on euronews ...
Collaborative COVID-19 research advanced metabolic phenotyping using NMR, revealing metabolic signatures of infection and more.
A new way to neutralize coronavirus and other membrane-surrounded viruses has been discovered by researchers from the Swedish University of Agricultural Sciences and the University of Tartu. Certain ...
April 25 (Reuters) - GlaxoSmithKline (GLAX.NS), opens new tab sued Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab in Delaware federal court on Thursday, accusing them of ...
Goad, PharmD, MPH, of Chapman University explains why pharmacists are trusted, accessible sources for COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results